Experimental evaluation of hepatoprotective activity of a new composition of oximethuracil with carbonic acids
- Authors: Repina E.F.1, Karimov D.O.1, Timasheva G.V.1, Khusnutdinova N.Y.1, Gimadieva A.R.2, Musina L.A.3, Mukhammadieva G.F.1, Baygildin S.S.1
-
Affiliations:
- Ufa Research Institute of Occupational Health and Human Ecology
- Ufa Institute of Chemistry, RAS
- All-Russian Center for Eye and Plastic Surgery of the Russian Health Ministry
- Issue: Vol 98, No 9 (2019)
- Pages: 1004-1010
- Section: EXPERIMENTAL INVESTIGATIONS
- Published: 14.10.2020
- URL: https://edgccjournal.org/0016-9900/article/view/639711
- DOI: https://doi.org/10.47470/0016-9900-2019-98-9-1004-1010
- ID: 639711
Cite item
Full Text
Abstract
Introduction. The high frequency of chemical poisoning is accompanied by an increase in the absolute number of cases of chemical damage to the liver. There is growing evidence that acute chemical poisoning in Russia is among the leading non-infectious diseases leading to premature death of male and female working-age people. It seems relevant to search for new pharmacological agents with low toxicity and high hepatoprotective activity, which increase the body’s stability under the influence of adverse environmental factors. The use of metabolic action drugs combining antioxidant and antihypoxic activity as hepatoprotectors is promising. The purpose of this study is an experimental evaluation of the hepatoprotective activity of a new composition of oxymethyluracil with succinic and fumaric acids.
Material and methods. The composition of 5-hydroxy-6-methyluracil with succinic and fumaric acids was first synthesized at the Ufa Institute of Chemistry. Using the model of acute liver toxic damage with carbon tetrachloride in laboratory animals, the prophylactic effect of a new drug was studied in comparison with heptor (ademetionine). Biochemical and morphological studies of laboratory animals’ biomaterial were conducted.
Results. The analysis showed that when using the studied drugs, biochemical parameters were close to the level of control animals. Morphological changes in the liver were less pronounced in the group of animals treated with the new composition, compared with changes in the structure of the liver of animals treated with heptorator (ademetionin).
Conclusion. The new composition of 5-hydroxy-6-methyluracil with succinic and fumaric acids has a protective effect on the liver of laboratory animals with the acute toxic effects of carbon tetrachloride, comparable, and in some cases, exceeding the preventive effect of heptoperam (ademetionine).
About the authors
Elvira F. Repina
Ufa Research Institute of Occupational Health and Human Ecology
Author for correspondence.
Email: noemail@neicon.ru
ORCID iD: 0000-0001-8798-0846
MD, Ph.D., senior researcher of the department of toxicology and genetics with an experimental clinic of laboratory animals Ufa Research Institute of Occupational Health and Human Ecology.
e-mail: e.f.repina@bk.ru
Russian FederationD. O. Karimov
Ufa Research Institute of Occupational Health and Human Ecology
Email: noemail@neicon.ru
ORCID iD: 0000-0003-0039-6757
Russian Federation
G. V. Timasheva
Ufa Research Institute of Occupational Health and Human Ecology
Email: noemail@neicon.ru
ORCID iD: 0000-0003-2435-6936
Russian Federation
N. Yu. Khusnutdinova
Ufa Research Institute of Occupational Health and Human Ecology
Email: noemail@neicon.ru
ORCID iD: 0000-0001-5596-8180
Russian Federation
A. R. Gimadieva
Ufa Institute of Chemistry, RAS
Email: noemail@neicon.ru
ORCID iD: 0000-0002-2995-310X
Russian Federation
L. A. Musina
All-Russian Center for Eye and Plastic Surgery of the Russian Health Ministry
Email: noemail@neicon.ru
ORCID iD: 0000-0003-1237-9284
Russian Federation
G. F. Mukhammadieva
Ufa Research Institute of Occupational Health and Human Ecology
Email: noemail@neicon.ru
ORCID iD: 0000-0002-7456-4787
Russian Federation
S. S. Baygildin
Ufa Research Institute of Occupational Health and Human Ecology
Email: noemail@neicon.ru
ORCID iD: 0000-0002-1856-3173
Russian Federation
References
- Ostapenko Yu.N., Litvinov N.N., Rozhkov P.G., Ilyashenko K.K., Goldfarb Yu.S. Problems of standardization of hospital care in clinical toxicology. Anesteziologiya i reanimatologiya. 2008; 6: 11–5. (in Russian)
- Onishchenko G.G. Actual issues of chemical and biological safety. Modern problems of hygienic science and occupational medicine. All-Russian scientific-practical conference with international participation. [Sovremennye problemy gigienicheskoj nauki i mediciny truda: Sbornik Vserossiyskoy nauchno-prakticheskoy konferentsii s mezhdunarodnym uchastiem]. Ufa; 2010: 17–9. (in Russian)
- Sanotskiy I.V. Palliative to the problem of protective measures for chemical impacts. Meditsina truda i promyshlennaya ekologiya [Occupational Health and Industrial Ecology]. 2007; 2: 10–4. (in Russian)
- Eremenko K.V. Optimal state of the body and adaptogens. [Optimalnoye sostoyaniye organizma i adaptogeny]. Saint Petersburg: ELBI-SPb; 2007. 136 p. (in Russian)
- Kutsenko S.A. Fundamentals of toxicology: Scientific and methodological publication [Osnovy toksikologii: Nauchno-metodicheskoye izdaniye]. SPb.: Folio; 2004. 570 p. (in Russian)
- Mashkovskiy M.D. Medicines:16th edition. [Lekarstvennyye sredstva: 16-е izdanie]. Moscow: Novaya volna; 2012. 1216 p. (in Russian)
- Skakun N.P. Liver damage by carbon tetrachloride [Porazheniye pecheni chetyrekhkhloristym uglerodom]. Moscow: NIITEKHIM; 1989. 196 p. (in Russian)
- Skakun. N.P., Moseychuk I.P., Gil L.L. The effectiveness of antioxidants in the combined defeat of the liver carbon tetrachloride and ethanol. Farmakologiya i toksikologiya. 1987; 3: 97–9. (in Russian)
- Saratikov. A.S., Vengerovskiy A.I. New medications of natural origin. Eksperimentalnaya i klinicheskaya farmakologiya. 1995; 1: 12–4. (in Russian)
- Cichoż-Lach H., Michalak A. Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol. 2014; 20 (25): 8082–91.
- Singal A.K., Jampana S.C., Weinman S.A. Antioxidants as therapeutic agents for liver disease. Liver Int. 2011; 31 (10): 1432–48.
- Voronina T.A., Smirnov L.D., Dyumayev K.M. Actual directions of use of Mexidol. Free radicals, antioxidants and human diseases. Proceedings of the national scientific-practical conference [Svobodnyye radikaly. antioksidanty i bolezni cheloveka: sbornik trudov natsionalnoy nauchno-prakticheskoy konferentsii]. Smolensk; 2001: 191–2. (in Russian)
- Golikov. S.N., Sanotskiy N.V., Tiunov L.A. General mechanisms of toxic action. [Obshchiye mekhanizmy toksicheskogo deystviya]. Moscow: Meditsina; 1986. 279 p. (in Russian)
- Abdullayev N.Kh., Karimov Kh.Ya. The liver during intoxication jatrovymi poisons. [Pechen pri intoksikatsii gepatropnymi yadami]. Tashkent: Meditsina; 1989. 96 p. (in Russian)
- Bilenko M.V. Ischemic and reperfusion injuries of organs (molecular mechanisms, ways of prevention and treatment) [Ishemicheskiye i reperfuzionnyye povrezhdeniya organov (molekulyarnyye mekhanizmy, puti preduprezhdeniya i lecheniya)]. M.: Meditsina. 1989. 368 p. (in Russian)
- Okovityy S.V., Smirnov A.V. Antigipoksanty. Eksperimentalnaya i klinicheskaya farmakologiya. 2001; 64 (3): 76–80. (in Russian)
- Li J., Li R.J., Lv G.Y., Liu H.Q. The mechanisms and strategies to protect from hepatic ischemia-reperfusion injury. Eur Rev Med Pharmacol Sci. 2015; 19 (11): 2036–47.
- Okovityy S.V., Bezborodkina N.N., Zarubina I.V. Study of hepatoprotective effect bemitil on the model of prolonged toxic hepatic damage. Eksperimentalnaya i klinicheskaya farmakologiya. 2006; 2: 52–4. (in Russian)
- Ivnitskiy Yu.Yu., Golovko A.I., Sofronov G.A. Succinic acid in the system of metabolic correction of the functional state and resistance of the body [Yantarnaya kislota v sisteme metabolicheskoy korrektsii funktsionalnogo sostoyaniya i rezistentnosti organizma]. Saint Petersburg; 1998. (in Russian)
- Semigolovskiy N.Yu. Clinical classification of antihypoxants. Pharmacotherapy of hypoxia and its consequences in critical conditions: Proceedings of the all-Russian conference. [Farmakoterapiya gipoksii i eye posledstviy pri kriticheskikh sostoyaniyakh: Materialy Vserossiyskoy konferentsii]. Saint Petersburg; 2004. (in Russian)
- Lukianova L.D. Modern problems of hypoxia. Vestnik RAMN. 2000; 9: 3–12. (in Russian)
- Lukianova L.D. Pharmacological correction of mitochondrial dysfunction in hypoxia. In: Ushakov I. B., Lukyanova L. D., ed. Problems of hypoxia: molecular, physiological and medical aspects. Moscow: Istoki; 2004: 456–87. (in Russian)
- Zarubina I.V., Lukk M.V., Shabanov P.D. Antihypoxic and antioxidant effects of exogenous succinic acid and aminothiol accentseasy antihypoxants. Byulleten’ eksperimental’noy biologii i meditsiny. 2012; 153 (3): 313–7. (in Russian)
- Leleka M., Zalis’ka O., Kozyr G. Screening research of pharmaceutical compositions based on succinic acid, ascorbic acid and rutin. J Pharm Pharmacol. 2016; 4: 486–91.
- Myshkin V.A., Enikeyev D.A. Overcoming hepatotoxicity with antioxidants: reality and perspective [Preodoleniye gepatotoksichnosti antioksidantami: realnost i perspektiv]. Ufa: Poligrafdizayn; 2014. 182 p. (in Russian)
- Myshkin V.A., Bakirov A.B., Repina E.F., Karimov D.O. Experimental pharmacocorrection of toxic liver lesions with antioxidants. [Eksperimentalnaya farmakokorrektsiya toksicheskikh porazheniy pecheni antioksidantami]. Ufa: Print-2; 2016. 173 p. (in Russian)
- Myshkin V.A., Enikeyev D.A., Srubilin D.A., Gimadiyeva A.R. Experimental evaluation of pyrimidine derivatives on models of toxic liver damage: review. Nauchnoye obozreniye. Meditsinskiye nauki [Scientific Review. Medical Science]. 2016; 03: 88–98. (in Russian)
- Vyshkatalyuk A.B., Semenov V.E., Zobov V.V., Galyametdinova I.V., Gumarova L.F., Parfenov A.A. Synthesis and primary assessment of hepatoprotective properties of new pyrimidine derivatives. Bioorganicheskaya khimiya. 2017; 43 (5): 572–80. (in Russian)
- Kudoyarov E.R., Karimov D.D., Karimov D.O., Smolyankin D.A., Repina E.F., Myshkin V.A. Evaluation of reparative activity of oxymethyluracil against the background of genotoxic effects on lymphocytes of mice. Hygiene, occupational pathology and public health risks. Materials of the all-Russian scientific-practical conference with international participation. [Gigiyena. profpatologiya i riski zdorovyu naseleniya. Materialy Vserossiyskoy nauchno-prakticheskoy konferentsii s mezhdunarodnym uchastiyem]. Ufa; 2016: 208–12. (in Russian)
- Repina E.F., Gimadiyeva A.R., Myshkin V.A., Bakirov A.B., Timasheva G.V., Khusnutdinova N.Yu. et al. Antihypoxic activity of a new complex compound of oxymethyluracil with sodium succinate. Toksikologicheskiy vestnik. 2017; 2: 40–2. (in Russian)
- Repina E.F., Myshkin V.A., Karimov D.O., Timasheva G.V., Khusnutdinova N.Yu., Smolyankin D.A. et al. Antihypoxic activity of complex compound oxymethyluracil with ascorbic acid. Toksikologicheskiy vestnik. 2018; 4: 20–3. (in Russian)
- Repina E.F., Khusnutdinova N.Yu., Timasheva G.V., Baygildin S.S., Karimov D.O., Musina L.A. et al. Morphological features of hepatoprotective action of antihypoxants in acute carbon tetrachloride in the experiment. Toksikologicheskiy vestnik. 2019; 1: 43–8. (in Russian)
- Gonskiy Ya.I., Korda M.M., Klits I.N. The effect of acetylcysteine on the antioxidant system in experimental toxic liver damage. Farmakologia i toksikologia. 1991; 54 (5): 44–6. (in Russian)
- Burobin V.A., Ponomareva O.V., Nikolayeva T.G., Yurchenko N.Ya. Study of the biological activity Eurocasinobet acid. Voprosy meditsinskoy khimii. 1985; 1: 102–6. (in Russian)
- Kamyshnikov V.S. Reference book on clinical and biochemical studies and laboratory diagnostics. [Spravochnik po kliniko-biokhimicheskim issledovaniyam i laboratornoy diagnostike]. Moscow: Medpress-infom; 2009. 320 p. (in Russian)
- Merkulov G.A. Course histopathological techniques [Kurs patogistologicheskoj tekhniki]. Moscow: Meditsina; 1969. 423 p. (in Russian)
- Burobin V.A., Likhacheva N.V. Determination of the activity of urokinase in serum and liver tissue. Micromethod. Laboratornoe delo. 1978; 11: 650–3. (in Russian)
- Koch A., Zimmermann H., Gassler N., Jochum C., Weiskirchen R., Bruensing J. et al. Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (su PAR) in acute liver failure. Liver Int. 2014; 34 (9): 1330–9.
- Sjöwall C., Martinsson K., Cardell K., Ekstedt M., Kechagias S.et al. Soluble urokinase plasminogen activator receptor levels are associated with severity of fibrosis in nonalcoholic fatty liver disease. Transl Res. 2015; 165 (6): 658–66.
- Myshkin V.A., Repina E.F., Galimov D.M., Timasheva G.V., Gimadiyeva A.R. Urokinase as a biochemical marker of liver PCB-containing drug “Sovtol-1” and the efficiency of correction of metabolic means. Actual problems of preventive medicine, environment and public health. Collection of scientific papers of the all-Russian scientific-practical conference with international participation. [Aktualnyye problemy profilakticheskoy meditsiny. sredy obitaniya i zdorovia naseleniya. Sbornik nauchnyh trudov Vserossijskoj nauchno-prakticheskoj konferencii s mezhdunarodnym uchastiem]. Ufa; 2013: 166–8. (in Russian)
Supplementary files
